Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives

Citations of this article
Mendeley users who have this article in their library.


So324 is a 2',3'-dideoxy-2',3'-didehydrothymidine-5'-monophosphate (d4T- MP) prodrug containing at the phosphate moiety a phenyl group and the methylester of alanine linked to the phosphate through a phosphoramidate linkage. So324 has anti-HIV activity in human CEM, MT4, and monocyte/macrophage cells that is superior to that of d4T. In contrast to d4T, So324 is also able to inhibit HIV replication in thyroidine kinase- deficient CEM cells. After uptake of So324 by intact human lymphocytes, d4T- MP is released and subsequently converted intracellularly to d4T-TP. In addition, accumulation of substantial amounts of a novel d4T derivative has been found. This d4T metabolite has been characterized as alaninyl d4T- MP. The latter metabolite accumulates at ≃13- to 200-fold higher levels than d4T-TP depending the experimental conditions. Alaninyl d4T-MP should be considered as an intra- and/or extracellular depot form of d4T and/or d4T- MP. These findings may explain the superior anti-retroviral activity of So324 over d4T in cell culture.




Balzarini, J., Karlsson, A., Aquaro, S., Perno, C. F., Cahard, D., Naesens, L., … Mcguigan, C. (1996). Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. Proceedings of the National Academy of Sciences of the United States of America, 93(14), 7295–7299.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free